Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
K Winter, R Talar-Wojnarowska, A Dąbrowski… - Gastroenterology …, 2019 - termedia.pl
These recommendations refer to the current management in pancreatic ductal
adenocarcinoma (PDAC), a neoplasia characterised by an aggressive course and extremely …
adenocarcinoma (PDAC), a neoplasia characterised by an aggressive course and extremely …
Endoscopic management of pancreaticobiliary disease
CF Vozzo, MR Sanaka - Surgical Clinics, 2020 - surgical.theclinics.com
Diagnostic and therapeutic modalities of pancreatic and biliary disease have changed
significantly over the past 50 years with the advancement of endoscopic retrograde …
significantly over the past 50 years with the advancement of endoscopic retrograde …
Advanced Imaging of the Biliary System and Pancreas
S Zhou, J Buxbaum - Digestive Diseases and Sciences, 2022 - Springer
Despite advances in noninvasive techniques for imaging the pancreaticobiliary system,
several disease processes including indeterminate biliary strictures as well as …
several disease processes including indeterminate biliary strictures as well as …
Current status of targeted microbubbles in diagnostic molecular imaging of pancreatic cancer
N Jugniot, R Bam, EJ Meuillet, EC Unger… - Bioengineering & …, 2021 - Wiley Online Library
Pancreatic ductal adenocarcinoma (PDAC) is often associated with a poor prognosis due to
silent onset, resistance to therapies, and rapid spreading. Most patients are ineligible for …
silent onset, resistance to therapies, and rapid spreading. Most patients are ineligible for …
Hereditary and sporadic pancreatic ductal adenocarcinoma: Current update on genetics and imaging
AC Morani, AK Hanafy, NS Ramani… - Radiology: Imaging …, 2020 - pubs.rsna.org
Pancreatic ductal adenocarcinoma (PDAC) is a genetically heterogeneous, biologically
aggressive malignancy with a uniformly poor prognosis. While most pancreatic cancers …
aggressive malignancy with a uniformly poor prognosis. While most pancreatic cancers …
The role of endoscopic ultrasound in pancreatic cancer staging in the Era of neoadjuvant therapy and personalised medicine
M Bispo, S Marques, R Rio-Tinto, P Fidalgo… - GE-Portuguese Journal …, 2021 - karger.com
Precise staging of pancreatic cancer is crucial for treatment choice. In clinical practice, this
includes the TNM staging and determination of tumour resectability, based on a …
includes the TNM staging and determination of tumour resectability, based on a …
[HTML][HTML] Accuracy of an administrative database for pancreatic cancer by international classification of disease 10th codes: a retrospective large-cohort study
YJ Hwang, SM Park, S Ahn, JC Lee… - World Journal of …, 2019 - ncbi.nlm.nih.gov
BACKGROUND Korean National Health Insurance (NHI) claims database provides large-
cohort. However, studies regarding accuracy of administrative database for pancreatic …
cohort. However, studies regarding accuracy of administrative database for pancreatic …
Endoscopic evaluation in the workup of pancreatic cancer
A Singh, AL Faulx - Surgical Clinics, 2016 - surgical.theclinics.com
Pancreatic cancer is a relatively rare disease and ranks 12th in terms of prevalence among
cancers in the United States, but it is the fourth leading cause of cancer related deaths. 1 It is …
cancers in the United States, but it is the fourth leading cause of cancer related deaths. 1 It is …
Performance of EUS-FNB in solid pancreatic masses: A lesson from 463 consecutive procedures and a practical nomogram
N Pagano, C Ricci, C Ingaldi, S Sadalla, A Fabbri… - Updates in Surgery, 2022 - Springer
The study's main goal was the diagnostic adequacy of pancreatic endoscopic
ultrasonographic (EUS) fine-needle biopsy (FNB) and associated predictive factors. The …
ultrasonographic (EUS) fine-needle biopsy (FNB) and associated predictive factors. The …
Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9
M Ono, Y Ono, T Nakamura, T Tsuchikawa… - Annals of Surgical …, 2022 - Springer
Background Pancreatic ductal adenocarcinoma (PDA) is a fatal cancer for which even
unfavorable clinicopathological factors occasionally fail to preclude long-term survival. We …
unfavorable clinicopathological factors occasionally fail to preclude long-term survival. We …